<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rajabli F</submitter><funding>NIA NIH HHS</funding><funding>BrightFocus Foundation</funding><funding>National Institutes of Health</funding><pagination>115.e1-115.e7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8851406</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>104</volume><pubmed_abstract>The genetic admixture of Caribbean Hispanics provides an opportunity to discover novel genetic factors in Alzheimer disease (AD). We sought to identify genetic variants for AD through a family-based design using the Puerto Rican (PR) Alzheimer Disease Initiative (PRADI). Whole-genome sequencing (WGS) and parametric linkage analysis were performed for 100 individuals from 23 multiplex PRADI families. Variants were prioritized by minor allele frequency (&lt;0.01), functional potential [combined annotation dependent depletion score (CADD) >10], and co-segregation with AD. Variants were further ranked using an independent PR case-control WGS dataset (PR10/66). A genome-wide significant linkage peak was found in 9p21 with a heterogeneity logarithm of the odds score (HLOD) >5.1, which overlaps with</pubmed_abstract><journal>Neurobiology of aging</journal><pubmed_title>Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus.</pubmed_title><pmcid>PMC8851406</pmcid><funding_grant_id>P30 AG066462</funding_grant_id><funding_grant_id>R01 AG070864</funding_grant_id><funding_grant_id>U01 AG057659</funding_grant_id><funding_grant_id>RF1 AG054074</funding_grant_id><funding_grant_id>U01 AG058654</funding_grant_id><pubmed_authors>Celis K</pubmed_authors><pubmed_authors>Bussies PL</pubmed_authors><pubmed_authors>Mena PR</pubmed_authors><pubmed_authors>Chinea A</pubmed_authors><pubmed_authors>Rodriguez VC</pubmed_authors><pubmed_authors>Reitz C</pubmed_authors><pubmed_authors>Griswold AJ</pubmed_authors><pubmed_authors>Haines JL</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Cuccaro ML</pubmed_authors><pubmed_authors>Pericak-Vance MA</pubmed_authors><pubmed_authors>Rajabli F</pubmed_authors><pubmed_authors>Acosta H</pubmed_authors><pubmed_authors>Van Booven DJ</pubmed_authors><pubmed_authors>Hofmann NK</pubmed_authors><pubmed_authors>Cukier HN</pubmed_authors><pubmed_authors>Prince MJ</pubmed_authors><pubmed_authors>Feliciano NI</pubmed_authors><pubmed_authors>Vardarajan BN</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors><pubmed_authors>Mayeux RP</pubmed_authors><pubmed_authors>Adams LD</pubmed_authors><pubmed_authors>Dalgard CL</pubmed_authors><pubmed_authors>Vance JM</pubmed_authors><pubmed_authors>Tejada S</pubmed_authors><pubmed_authors>Beecham GW</pubmed_authors><pubmed_authors>Hamilton-Nelson KL</pubmed_authors><pubmed_authors>Whitehead PL</pubmed_authors><pubmed_authors>Prough M</pubmed_authors><pubmed_authors>Jimenez IZ</pubmed_authors><pubmed_authors>Feliciano-Astacio BE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus.</name><description>The genetic admixture of Caribbean Hispanics provides an opportunity to discover novel genetic factors in Alzheimer disease (AD). We sought to identify genetic variants for AD through a family-based design using the Puerto Rican (PR) Alzheimer Disease Initiative (PRADI). Whole-genome sequencing (WGS) and parametric linkage analysis were performed for 100 individuals from 23 multiplex PRADI families. Variants were prioritized by minor allele frequency (&lt;0.01), functional potential [combined annotation dependent depletion score (CADD) >10], and co-segregation with AD. Variants were further ranked using an independent PR case-control WGS dataset (PR10/66). A genome-wide significant linkage peak was found in 9p21 with a heterogeneity logarithm of the odds score (HLOD) >5.1, which overlaps with</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2026-05-08T11:36:39.823Z</modification><creation>2025-04-06T09:24:12.978Z</creation></dates><accession>S-EPMC8851406</accession><cross_references><pubmed>33902942</pubmed><doi>10.1016/j.neurobiolaging.2021.02.019</doi></cross_references></HashMap>